Amiral Gestion Boosts Stock Position in Colgate-Palmolive Company $CL

Amiral Gestion boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 575.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 141,873 shares of the company’s stock after buying an additional 120,873 shares during the period. Colgate-Palmolive accounts for about 4.1% of Amiral Gestion’s investment portfolio, making the stock its 9th biggest holding. Amiral Gestion’s holdings in Colgate-Palmolive were worth $11,211,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive during the third quarter worth $29,000. Cloud Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth $30,000. Global Wealth Strategies & Associates grew its stake in Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after buying an additional 300 shares during the last quarter. Grove Bank & Trust increased its position in Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after buying an additional 263 shares in the last quarter. Finally, Kelleher Financial Advisors purchased a new stake in Colgate-Palmolive in the third quarter valued at about $35,000. 80.41% of the stock is currently owned by institutional investors.

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock worth $17,486,693 over the last three months. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.1%

Shares of CL stock opened at $84.25 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a market cap of $67.59 billion, a price-to-earnings ratio of 32.16, a PEG ratio of 3.77 and a beta of 0.28. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The stock has a 50 day simple moving average of $91.11 and a 200-day simple moving average of $83.38.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 EPS. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Wall Street Analyst Weigh In

CL has been the subject of several recent analyst reports. UBS Group raised their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Barclays lifted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Jefferies Financial Group raised their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.